Mar. 28 2024
Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directionsFound: of palliative care/s upport irrespective of age . 3 OB00 3 The contractor e stablishes and maintains
Mar. 28 2024
Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directionsFound: immediately opposite the entry in column 1 in respect of meningococcal vaccine (MenC), insert — “(a) Children
Mar. 28 2024
Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directionsFound: (7) The part of the Achievement Payment that relates to— (a) the palliative care area of the
Mar. 28 2024
Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directionsFound: review in the preceding 12 months (NICE 2012 menu ID: NM58) 5 40–90% Palliative care (PC
Mar. 28 2024
Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directionsFound: vaccin es and immunisations), in the third row of the table in paragraph I.1.3 (immunisations for children
Mar. 28 2024
Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directionsFound: review in the preceding 12 months NICE 2012 menu ID: NM58 5 40–90% Palliative care (PC) Indicator
Mar. 28 2024
Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directionsFound: D.11 A personalised care adjustment may be applied to the care of a registered patient who is in the
Correspondence Mar. 28 2024
Committee: Health, Social Care and Sport CommitteeFound: National Care Service (Scotland) Bill Stage 1 report full response Letter from the Minister for Social
Mar. 25 2024
Source Page: The Disability Assistance (Scottish Adult Disability Living Allowance) Regulations 2024Found: (2) An individual who satisfies the relevant component of the care criterion in paragraph (1) before
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023Found: a Phase II, single -blinded, active -controlled, randomised study in approximately 300 healt hy children